OBJECTIVE: This study investigated whether ischaemic postconditioning can improve recovery of myocardial contractile function in acute myocardial infarction patients 1 week and 6 months after angioplasty. METHODS: A total of 62 patients undergoing direct percutaneous coronary intervention after acute myocardial infarction were randomly assigned to receive four episodes of inflation and deflation of the angioplasty balloon in the early reperfusion period (postconditioned group, n = 32), or no additional intervention (control group, n = 30). Two-dimensional size and left ventricular (LV) global and regional contractile functions were then evaluated by echocardiography at 1 week and 6 months after angioplasty. RESULTS: At 1 week, there were no significant differences in left atrial diameter, LV enddiastolic diameter, LV end-diastolic volume, cardiac output, LV ejection fraction or wall motion score index between the two groups. At 6 months, LV ejection fraction was significantly increased and the wall motion score index significantly reduced in the postconditioned group compared with the control group. CONCLUSION: Ischaemic postconditioning can improve long-term LV contractile function 6 months after reperfusion following acute myocardial infarction.
Introduction
Acute myocardial infarction is common and severe. Myocardial infarction with ST elevation continues to be a major public health problem in industrialized countries and is an increasing problem in developing countries. 1,2 It has been estimated that 500 000 ST-elevation myocardial infarction events occur each year in the USA. 1 Efficient reperfusion strategies, such as primary percutaneous coronary intervention (PCI) and thrombolysis, have been shown to a CM Zhao and JH Yang contributed equally to this work. Postconditioning and left ventricular contractile function improve the outcome of patients with acute myocardial infarction. 3 Reperfusion, however, brings a series of problems, including myocardial stunning, ventricular arrhythmias and no reflow, 4 and the reduction of reperfusion injury has become an important therapeutic target.
The concept of ischaemic postconditioning was first described by Zhao et al. 5 and involves inducing brief episodes of ischaemia during the early reperfusion period. Zhao et al. 5 reported that ischaemic postconditioning reduced infarct size in a dog model, and Staat et al. 6 subsequently demonstrated that this protection also applied to the human heart. In a 'proof-ofconcept' study, they showed that four episodes of 1-min inflation / 1-min deflation of the angioplasty balloon immediately after direct stenting of the occluded coronary artery reduced total creatine kinase release, an estimate of infarct size, by 36% during reperfusion in patients with acute myocardial infarction. 6 More recently, Thibault et al. 7 demonstrated that ischaemic postconditioning improved myocardial contractile function on echocardiography 1 year after infarction.
The present study aimed to investigate whether ischaemic postconditioning improves myocardial contractile function as evaluated by echocardiography 1 week and 6 months after angioplasty.
Patients and methods

PATIENT RECRUITMENT AND RANDOMIZATION
Patients eligible for inclusion in the study were those who presented to the First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, China, between November 2008 and March 2011.
Inclusion criteria were: acute myocardial infarction age > 18 years, ≤ 12 h from onset of chest pain, ST-segment elevation > 1 mm in two contiguous leads on electrocardiography, occlusion of the culprit coronary artery, thrombolysis in myocardial infarction (TIMI) flow grade 8 of 0 at the time of admission, and PCI chosen as the treatment of choice. Patients with the following conditions were excluded: cardiac arrest, cardiogenic shock, previous acute myocardial infarction, occurrence of angina within 48 h of myocardial infarction (to exclude the potential benefit of protection by preconditioning), and evidence of coronary collaterals (Rentrop grade ≥ 1) 9 to the risk region as assessed by coronary angiography on admission.
A pre-established randomization list was used to assign patients either to the control group or to the postconditioned group.
Written informed consent was obtained from all patients and the study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, China.
PCI AND POSTCONDITIONING
Coronary angiography and angioplasty were performed in all patients using standard techniques. The tip of the angioplasty guidewire was positioned downstream of the culprit lesion and the balloon was inflated for approximately 20 s at a pressure of 12 -16 atm. In the control group, no additional intervention was performed during the first 8 min of reperfusion. In the postconditioned group, within 1 min of reflow, the angioplasty balloon was reinflated four times for 1 min using low-pressure (4 -6 atm) inflations, each separated by 1 min of reflow. 6 In both groups the PCI procedure then continued routinely, with repositioning of the balloon for implantation of a stent when the stenosis diameter was ≥ 50% of the diameter of the culprit artery.
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At 1 week and 6 months after angioplasty, all patients were scanned in the left supine position using the Vivid 7 cardiovascular ultrasound system (GE Healthcare, Piscataway, NJ, USA). Left ventricular (LV) end-diastolic volume and LV ejection fraction were measured using the biplane Simpson's rule. 10 Cardiac output was calculated based on the LV ejection fraction. To evaluate regional systolic function, the left ventricle was divided according to the 16segment model recommended by the American Society of Echocardiography. 10 For each segment, wall motion was scored from 1 (normal) to 4 (dyskinetic) and the wall motion score index was derived as the sum of all the scores divided by the number of segments visualized. Left atrial diameter and LV end-diastolic diameter were measured using M-mode ultrasound, guided by the parasternal long-axis image.
STATISTICAL ANALYSES
The mean ± SD were calculated for the data. All analyses were performed by independent observers blinded to the treatment groups. The PCI cardiologist was not involved in any of the data analyses. Comparisons between continuous variables were performed using the independent-samples t-test. Categorical variables were compared using the likelihood ratio test. A P-value < 0.05 was considered to be statistically significant. Statistical analyses were carried out using SPSS ® software version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
A total of 68 patients aged 59 ± 12 years met the eligibility criteria during the study period. Of these, six were subsequently excluded from the study: one patient died, two moved away and three chose to leave the study. Of the remaining 62 patients, 30 were randomized to the control group and 32 to the postconditioned group.
There were no significant intergroup differences in age, sex, body mass index or clinical characteristics, including ischaemia time, culprit artery and drug treatment (Table 1) .
Revascularization was performed successfully in all cases to give a reperfusion TIMI flow grade > 2. Stenting was performed in 60 of the 62 patients without any adverse events such as coronary artery perforation, vessel dissection, stent thrombosis or coronary stent migration. Stenting was not performed in the remaining two patients, who were both in the control group, because the stenosis diameter was < 50% of the diameter of the culprit artery and so did not meet the requirement for stenting. In the postconditioned group, the repeated balloon inflations were performed safely.
Echocardiographic findings at 1 week showed no statistically significant differences in LA diameter, LV end-diastolic diameter, LV end-diastolic volume, cardiac output, LV ejection fraction or wall motion score index between the two groups (Table 2) . At 6 months, LV ejection fraction was significantly increased and the wall motion score index was significantly reduced in the postconditioned group compared with the control group (P = 0.016 and P = 0.005, respectively; Table 3 ). There were no significant differences between the two groups in the other parameters measured at 6 months.
Discussion
The concept of ischaemic preconditioning was first introduced by Murry et al. 11 in 1986, when they reported that it significantly reduced infarct size. Preconditioning, however, needs to be carried out prior to a prolonged ischaemic insult and is, therefore, CM Zhao, XJ Yang, JH Yang et al.
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difficult to apply in the clinical situation. In 2003, however, Zhao et al. 5 reported that brief episodes of ischaemia induced just at the onset of reperfusion following a prolonged period of ischaemia -ischaemic postconditioning -significantly reduced infarct size in a similar way to ischaemic preconditioning. This was subsequently confirmed in several animal studies. 12 -14 Compared with ischaemic preconditioning, 7 demonstrated that ischaemic postconditioning provided a persistent infarct size reduction at 6 months and improved recovery of myocardial contractile function at 1 year after reperfusion in acute myocardial infarction patients.
In the present study, both the short-(1 week) and long-term (6 months) effects of ischaemic postconditioning were studied. Short-term follow-up showed that all the parameters measured, including LV ejection fraction and wall motion score index, were similar in the control group and the postconditioned group. Long-term follow-up demonstrated better contractile function, evidenced by an increased LV ejection fraction and reduced wall motion score index, in the postconditioned group compared with controls. These findings suggest, therefore, Data presented as mean ± SD. There were no statistically significant between-group differences (P ≥ 0.05); independent-samples t-test. 7 reported benefits 1 year after angioplasty. Even longer term follow-up may, therefore, be required to demonstrate the full extent of the benefits of ischaemic postconditioning.
Ischaemic postconditioning has been shown to lead to reduced infarct size, indicating improved contractile function. 15 -19 Zhao et al., 5 however, reported that ischaemic postconditioning did not improve myocardial segment contractile function in the first 3 h after reperfusion in dog heart. In addition, Couvreur et al. 20 and Vinten-Johansen et al. 21 reported that ischaemic postconditioning did not protect against myocardial stunning in dogs and rabbits. These studies may help to explain the different short-and long-term effects of ischaemic postconditioning seen in the present study: myocardial stunning might influence the beneficial effect on contractile function during the early days and weeks after reperfusion but, as time elapses, the beneficial effect of ischaemic postconditioning is revealed once the vitality of the stunned myocardium is recovered. 22, 23 An important limitation of the present study was the small population size. Another limitation was that echocardiography could not be performed on the same day as reperfusion in view of restrictions required for this investigation and the serious condition of the patients. In addition, 6 months may not be long enough for the benefits of ischaemic postconditioning to be fully evident; follow-up after 1 year may be more appropriate. Nevertheless, the initial objective of demonstrating the benefits of postconditioning was achieved.
In conclusion, the present study supports the idea that ischaemic postconditioning is associated with improved LV contractile function detectable 6 months after reperfusion following acute myocardial infarction. Due, however, to the limited number of clinical studies of ischaemic postconditioning, further studies with larger sample sizes and longer term follow-ups are necessary to investigate more fully and to understand the protective benefits of ischaemic postconditioning before widespread use of this technique in acute myocardial infarction patients.
